JPMorgan Starts Kythera Biopharmaceuticals (KYTH) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Goldman Sachs Starts Kythera Biopharmaceuticals (KYTH) at Neutral
November 5, 2012 9:11 AM ESTGoldman Sachs initiates coverage on Kythera Biopharmaceuticals (NASDAQ: KYTH) with a Neutral. PT $23.00.
The analyst comments: "Kythera's story is driven by ATX-101, a first-in-class injectable product for localized fat reduction that we believe holds both a high likelihood of achieving FDA approval and... More
Leerink Swann Starts Kythera Biopharmaceuticals (KYTH) at Outperform; Next Big Think in Facial Aesthetics
November 5, 2012 8:48 AM ESTLeerink Swann initiates coverage on Kythera Biopharmaceuticals (NASDAQ: KYTH) with a Outperform. PT $28.00.
The firm comments: "We recommend purchase of KYTH based on (1) compelling prospects for clinical and regulatory success in the US and Europe for a first-inclass product (ATX-101) for the treatment of... More
Lazard Capital Starts Kythera Biopharmaceuticals (KYTH) at Buy
November 5, 2012 8:43 AM ESTLazard Capital initiates coverage on Kythera Biopharmaceuticals (NASDAQ: KYTH) with a Buy. PT $32.00.
For an analyst ratings summary and ratings history on Kythera Biopharmaceuticals click here. For more ratings news on Kythera Biopharmaceuticals click here.
Shares of Kythera Biopharmaceuticals closed at $22.11 yesterday, with a 52 week range of $18.49-$25.30.... More
